Entheon Biomedical, Timothy Ko, CEO



Entheon Biomedical CEO Timothy Ko stopped by TraderTV Live, . The biotechnology company focused on developing psychedelic medicines to treat addiction and further develop its portfolio of Dimethyltryptamine (DMT) based psychedelic therapeutic products for treating addiction and substance use disorders. Entheon focuses on providing therapeutics for severe depression, severe Post-traumatic stress disorder (PTSD) and treatment resistant depression.. ********* Watch our Live Trading show, Monday to Friday from 9 am to Noon! https://www.youtube.com/tradertvlive

DISCLAIMER

Legal Notice: The views and opinions expressed on TraderTV.Live are provided for information purposes only and should NOT be taken as (a) a solicitation of an offer to buy or sell a security, (b) an endorsement or recommendation of any particular security or trading strategy, or (c) investment advice.

The trading activity shown on TraderTV.Live are stocks, futures and Forex purchases and sales, using real money and real-time market data. Our traders may own the securities they are trading on TraderTV.Live in their personal portfolios.

BEFORE MAKING ANY INVESTMENT DECISION, IT IS STRONGLY RECOMMENDED YOU SEEK ADVICE FROM A QUALIFIED BROKER OR INVESTMENT ADVISOR.

TRADERTV.LIVE DOES NOT PROVIDE OR GUARANTEE ANY FINANCIAL, LEGAL, TAX, OR ACCOUNTING ADVICE OR ADVICE REGARDING THE SUITABILITY, PROFITABILITY, OR POTENTIAL VALUE OF ANY PARTICULAR SECURITY, TRADING STRATEGY, OR INFORMATION SOURCE.

This segment of TraderTV.Live features an interview of a representative of a company publicly traded in the United States (the “Profiled Issuer”) discussing the company, its business, and/or its prospects (the “Information”). TraderTV.Live has not reviewed or vetted, and does not make any comment on or otherwise endorse, the accuracy, relevance, or completeness of the Information. Since we have been paid to disseminate the Information to the public pertaining to securities of the Profiled Issuer, we are required by Section 17(b) of the Securities Act of 1933, as amended, to specifically disclose our compensation. TraderTV.Live received payment of 3000 Canadian dollars from the Profiled Issuer’s media representative as consideration for the Profiled Issuer’s representative being interviewed on the show.

The Information presented during the interview is a snapshot and may provide only positive information about the Profiled Issuer. TraderTV.Live has not been retained to exercise content control over what representations the Profiled Issuer’s representative chooses to make regarding the Profiled Issuer.

No representation is made as to the liquidity of the securities of the Profiled Issuer. If the Profiled Issuer’s securities are illiquid, new viewer interest in the Information – even if the Information has already been disclosed on EDGAR – may itself result in increased buyer demand for the securities, thereby increasing their price.

TraderTV.Live is not responsible for any errors or omissions in the Information or for any viewer’s use of the Information.

VIEWERS ARE ENCOURAGED TO CONDUCT THEIR OWN RESEARCH INTO THE PROFILED ISSUER AND, IF INTERESTED IN TRADING ITS SECURITIES, TO OBTAIN ADVICE FROM A QUALIFIED BROKER OR INVESTMENT ADVISOR.

All content appearing on TraderTV.Live is protected by copyright law. Rebroadcasting or any other commercialized use of our program content is strictly prohibited.

Source: Youtube